Eucrates Biomedical Acquisition Corp (EUCRU)

Etorro trading 970x250

About Eucrates Biomedical Acquisition Corp

Eucrates Biomedical Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York. Address: 250 West 55Th Street, New York, NY, United States, 10019

Eucrates Biomedical Acquisition Corp News and around…

Latest news about Eucrates Biomedical Acquisition Corp (EUCRU) common stock and company :

Eucrates Biomedical Acquisition Corp. Receives Expected Notice From Nasdaq Regarding Delayed Quarterly Report
01 Jun, 2021 Yahoo! Finance

Eucrates Biomedical Acquisition Corp. (Nasdaq: EUCR) (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, today announced that it received a notice ("Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the "Form 10-Q") with the Securities and Exchange Commission ("SEC"). The Notice has no immediate effect on the listing or trading of the Company's securities on the Nasdaq Capital Market.

Here's What Eucrates Biomedical Acquisition Corp.'s (NASDAQ:EUCR) Shareholder Ownership Structure Looks Like
11 May, 2021 Yahoo! Finance

If you want to know who really controls Eucrates Biomedical Acquisition Corp. ( NASDAQ:EUCR ), then you'll have to look...

Eucrates Biomedical Acquisition Corp. Announces The Separate Trading Of Its Ordinary Shares And Redeemable Warrants
14 Dec, 2020 Yahoo! Finance

Eucrates Biomedical Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, today announced that holders of the units sold in the Company's initial public offering of 10,000,000 units, may elect to separately trade the ordinary shares and redeemable warrants included in the units. Those units not separated will continue to trade on The Nasdaq Capital Market ("Nasdaq") under the symbol "EUCRU," and the ordinary shares and redeemable warrants that are separated will trade on the Nasdaq under the symbols "EUCR" and "EUCRW," respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into ordinary shares and redeemable warrants.

Eucrates Biomedical Acquisition Corp. Announces Closing Of $100 Million Initial Public Offering
27 Oct, 2020 Yahoo! Finance

Eucrates Biomedical Acquisition Corp. (the "Company"), a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, today announced the closing of its initial public offering of 10,000,000 units at an initial public offering price of $10.00 per unit. The units are listed on The Nasdaq Capital Market ("Nasdaq") and commenced trading under the ticker symbol "EUCRU" beginning on October 23, 2020. Each unit consists of one ordinary share of the Company and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one ordinary share of the Company at an exercise price of $11.50 per share. Once the securities comprising the units begin separate trading, the ordinary shares and warrants are expected to be listed on Nasdaq under the symbols "EUCR" and "EUCRW," respectively.

Eucrates Biomedical Acquisition Corp (EUCRU) is a NASDAQ Common Stock listed in

970x250